Mirae Asset Venture Investment

Mirae Asset Venture Investment is a South Korea-based asset management firm founded in 1997, with a global presence spanning 12 countries, including Australia, the United States, and various Asian markets. The company focuses on providing innovative investment solutions and financial strategies tailored to meet the diverse needs of its clients. Its offerings encompass traditional equity and fixed income products, exchange-traded funds, and alternative strategies such as hedge funds. Committed to ethical standards and client-centric principles, Mirae Asset emphasizes teamwork and the recruitment of top talent to drive its success. The firm aims to identify value-generating investment opportunities while adhering to a philosophy centered on building strong, lasting relationships within the communities it serves.

Eunhye (Haley) Kim

Senior Investment Manager

Hyeon-Joo Park

Founder

Suhyung Yoo

Venture Capitalist (Senior Manager)

Past deals in Skincare

Best Innovation

Seed Round in 2025
Best Innovation is a manufacturer of cosmetic products intended to offer a safe alternative to harmful skincare chemicals.

Eul Biosciences

Series A in 2024
Eul Biosciences is a biotechnology company that develops regenerative aesthetic cosmetics and wound dressing products.

Rael

Series B in 2022
Rael is a Los Angeles-based company that specializes in menstrual care and feminine wellness products made from natural and organic ingredients. Founded by three female entrepreneurs, Rael aims to empower women by offering safe and healthy alternatives to conventional feminine care items. The company's product range includes pads, tampons, pantyliners, period underwear, feminine washes, and wipes, all designed to prioritize comfort and quality. Additionally, Rael has ventured into the clean beauty market, introducing products such as natural face sheet masks made from botanical ingredients. The brand has gained significant traction, becoming a bestseller on Amazon and expanding its availability to Target stores and 13 countries. Since its establishment in 2017, Rael has attracted investment from various industry leaders, reflecting its commitment to promoting healthier options for women's personal care.

Soldak

Seed Round in 2021
Soldak is a health care mobile app that sells hair care, skin care, and diet products

Cardon

Seed Round in 2021
Cardon Inc. is a New York-based company that specializes in manufacturing cactus-based personal care grooming products specifically designed for men. Founded in 2019, Cardon offers a range of premium skincare items, including face sunscreen, face wash, and night moisturizer, all inspired by Korean grooming innovations. The brand's mission is to simplify the shopping experience for men, making high-quality skincare accessible at an affordable price. Cardon serves its customers primarily through its online store, catering to individual male grooming needs by addressing common skin and hair concerns.

Rael

Series A in 2018
Rael is a Los Angeles-based company that specializes in menstrual care and feminine wellness products made from natural and organic ingredients. Founded by three female entrepreneurs, Rael aims to empower women by offering safe and healthy alternatives to conventional feminine care items. The company's product range includes pads, tampons, pantyliners, period underwear, feminine washes, and wipes, all designed to prioritize comfort and quality. Additionally, Rael has ventured into the clean beauty market, introducing products such as natural face sheet masks made from botanical ingredients. The brand has gained significant traction, becoming a bestseller on Amazon and expanding its availability to Target stores and 13 countries. Since its establishment in 2017, Rael has attracted investment from various industry leaders, reflecting its commitment to promoting healthier options for women's personal care.

APR Corporation

Series B in 2018
APR is a global beauty-tech company expands beyond beauty with “Medicube” leading the charge.

General Bio

Venture Round in 2015
General Bio specializes in the development of innovative biomaterials derived from microorganisms and natural ingredients. The company focuses on creating a range of products, including functional cosmetics, bio-cosmetics, health food supplements, and eco-friendly detergents. Notably, General Bio has developed ALA (5-Aminolevulinic acid) and MAL (Methyl Aminolevulinate acid) using advanced microbiology technology, which are registered with international cosmetic authorities. Additionally, the company utilizes ginseng saponins, such as compound K and Rg2, to enhance metabolism in its bio-food and cosmetic offerings. Through its commitment to natural and effective products, General Bio aims to promote health and reduce environmental impact.

General Bio

Seed Round in 2015
General Bio specializes in the development of innovative biomaterials derived from microorganisms and natural ingredients. The company focuses on creating a range of products, including functional cosmetics, bio-cosmetics, health food supplements, and eco-friendly detergents. Notably, General Bio has developed ALA (5-Aminolevulinic acid) and MAL (Methyl Aminolevulinate acid) using advanced microbiology technology, which are registered with international cosmetic authorities. Additionally, the company utilizes ginseng saponins, such as compound K and Rg2, to enhance metabolism in its bio-food and cosmetic offerings. Through its commitment to natural and effective products, General Bio aims to promote health and reduce environmental impact.

Neothetics

Series C in 2013
Neothetics, Inc. was a clinical-stage specialty pharmaceutical company focused on developing therapeutics for the aesthetic market. Founded in 2007 and based in San Diego, California, the company aimed to address cosmetic concerns through innovative treatments. Its primary product candidate, LIPO-202, was an injectable formulation designed to reduce localized fat deposits, specifically targeting submental fat under the chin and central abdominal bulging in non-obese individuals. In January 2018, Neothetics was acquired by Evofem Biosciences in a reverse merger transaction, marking a significant shift in its business trajectory. The company was previously known as Lipothera, Inc. before rebranding in August 2014.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.